FLAME 30
Photomedicine: Technologies and Global Markets
Report Highlights
The global market of photomedicine, including drugs and devices, was valued at $609.7 million in 2013. The market is expected to reach $616.8 million in 2014 and $754 million in 2019, a compound annual growth rate (CAGR) of 4.1% for the five-year period, 2014 to 2019.
Report Includes
- An overview of the global markets for photomedicine, a field of medicine that comprises pathologies caused by light and therapeutic applications of light itself.
- Analyses of global market trends, with data from 2013, estimates for 2014, and projections of CAGRs through 2019.
- Information focused on medical equipment (such as lasers, light emitting diodes and other kinds of light technologies) which are employed to treat and diagnose a variety of diseases like skin conditions (psoriasis, vitiligo, cancer etc), seasonal and non-seasonal medical conditions, sleep disorders, and more.
- Coverage of therapeutic areas will include dermatology, surgery, optical diagnostics, cardiology, and oncology.
- Analysis of important market dynamics such as growth drivers, inhibitors, and opportunities.
- Comprehensive company profiles of major players in the photomedicine industry.
SCOPE OF THE REPORT
The global market of photomedicine will grow to about $754 million by 2019 at a compound annual growth rate of 4.1% from 2014 to 2019. This report provides a detailed segmentation by region, by products and type of products, by therapeutic areas and by type of treatment. Profiles of key market players are also included. Major products that generate the largest revenues, as well as the most-valuable R&D products that will come on the market up to 2019 are provided.
In-depth competitive market analysis is discussed, with examples of how new products will enter the market or how existing products will survive or perish. The report also includes descriptions of current and future technologies for drugs and devices used in photomedicine. In the future, nanotechnology will play a pivotal role in drug and discovery innovation.
ANALYST’S CREDENTIALS
Alessandro Varotto has a PhD in Chemistry with a specialty in Nanotechnology and Materials Science. Dr. Varotto has worked as a research scientist in both academic and industry environments. He is the author of about 20 peer-reviewed research articles, patents, a book and dozens of technical papers in the field of life science. His expertise includes chemistry and nanomaterials for the pharmaceutical and medical device industries.
